Fibromyalgia: Diagnosis and Management Save

Know-it-now

• Fibromyalgia is characterized by widespread pain involving any body tissue and is accompanied by fatigue and problems with sleep, mood, and memory.
• The central nervous system (CNS) is hyperresponsive to sensory stimuli generally.
• Diagnosis is clinical, not baed on labs or imaging; testing is only to screen for mimics.
• Treating Sleep is paramount.
• Stretching therapies (tai chi, qigong, yoga) CBT are highly effective, but underprescribed .

Fibromyalgia (FM) affects 4–6% of the U.S. population, with nearly a 2 fold female predominance. Nociplastic pain underlies the pathophysiology of FM. CNS hypersensitization to both painful and non-painful stimuli occurs with little or no tissue pathology. This can arise top-down (pre-existing CNS traits — sleep disruption, memory complaints, sensory hypersensitivity) that precede pain onset or bottom-up (secondary to arthritis, damage, autoimmune disease, hypermobility, painful considtions, sickle cell disease, or repeated nociceptive exposure). Framing FM as a disorder of CNS processing is critical to diagnosis, treatment approaches and patient buy-in.

There is no laboratory or imaging test for fibromyalgia — attempts to validate small-fiber neuropathy or autoimmune mechanisms remain unsubstantiated. The 2016 ACR criteria are the modern standard:

• Widespread Pain Index (WPI): pain in ≥4 of 5 body regions (19-site body map)
• Symptom Severity Score (SSS): captures fatigue, sleep, cognition, mood
• Fibromyalgia Severity score >13 confirms diagnosis

Labs (ESR, CRP, TSH, CBC, LFTs) may be used only to screen for mimics/comorbidities, but are unnecessary to diagnose FM.  There are numerous overlapping disorders that coassociate with FM - IBS, TMD, migraine, interstitial cystitis, endometriosis, ME/CFS, POTS, and there are tools that can be used to identify these (PROMIS-29+2 and the Chronic Overlapping Pain Conditions Screener- COPC-S), but these are seldon necessary in practice.

Treatment Principles

1. Sleep: Sleep disruption is a core driver of nociplastic pain, and many preferred FM drug effects (tricyclics, gabapentinoids) appear to work substantially through restoration of deep sleep rather than direct analgesia. Cognitive behavioral therapy (CBT) for insomnia is explicitly recommended but is underutilized in FM management.

2. Patient education + self-care promotion:

   • Reassurance that pain is real, chronic but manageable, and not tissue-destructive. 

   • Self-care goals include pacing, sleep hygiene, stress management, and pleasant-activity scheduling.

3. Movement therapies - are still underutilized despite strong evidence

   • Exercise has major effects on pain control (muscle strengthening even larger. 

   • Stretching: qigong, tai chi, and yoga carry "strong recommendation" status yet are rarely prescribed in routine rheumatology practices. Tai chi alone shows a medium effect on sleep.

4. Behavioral: CBT remains best-studied (modest effects on pain, FM symptoms, anxiety and is underused; worthy of wider adoption.

5. Pharmacologic: most commonly used agents (muscle relaxants, tricyclics, gabapentinoids and SNRIs) have only been shown to have small to modest treatment effects, and where effective are largely mediated via their ability to promote better sleep. there have been several recent advances in treatment.

   • Sublingual cyclobenzaprine newly FDA-approved for FM

   • Combination therapy outperforms monotherapy: gabapentinoid (bedtime) + SNRI (daytime) achieved 68% global pain relief at 6 weeks vs. 42% (duloxetine alone), 39% (pregabalin alone), 18% (placebo)

   • Avoid NSAIDs and opioids — opioids nearly double all-cause mortality in this population via endogenous opioid-induced hyperalgesia

   • Low-dose naltrexone is an emerging, underrecognized option

   • Emerging treatment options: transcranial magnetic/direct-current stimulation, TENS, cannabinoids (CBD vs. THC balance still unclear)

Most fibromyalgia can and should be diagnosed and managed in primary care/rheumatology without extensive workup. Specialist referral is reserved for confirming diagnosis, ruling out mimics, or a one-time consultation when autoimmune disease/neuropathy coexists.